Research Paper Volume 13, Issue 4 pp 5946—5966

Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma

class="figure-viewer-img"

Figure 1. The expression of AURKB in LUAD patients and its association with clinical characteristics. (A) AURKB expression difference between lung adenocarcinoma samples and normal samples; (BE) AURKB expression in different subgroups characterized by TNM staging system (B) T for tumor size; (C) N for lymph node invasion; (D) M for distant metastasis; (E) stage); (F) AURKB expression in smokers and non-smokers. (G) Meta-analysis of AURKB expression in tumor and normal tissues based on different datasets by Lung Cancer Explorer (LCE).